Literature DB >> 11432431

Intramuscular kinetics and dosage regimens for pralidoxime in buffalo calves (Bubalus bubalis).

A K Srivastava1, J K Malik.   

Abstract

The plasma levels, disposition kinetics and a dosage regimen for pralidoxime (2-PAM) were investigated in male buffalo calves following single intramuscular administration (15 or 30 mg/kg). The effects of 2-PAM on various blood enzymes were also determined. The absorption half-life, elimination half-life, apparent volume of distribution and total body clearance of 2-PAM were 1.08 +/- 0.19 h, 3.14-3.19 h, 0.83-1.01 L/kg and 184.9-252.1 ml/(kg h), respectively. At doses of 15 and 30 mg/kg body weight, a plasma concentration > or = 4 microg/ml was maintained for up to 4 and 6 h, respectively. Pralidoxime significantly lowered the serum level of transferases, phosphatases and lactate dehydrogenase but did not influence the acetylcholinesterase and carboxylesterase enzymes. The most appropriate dosage regimen for 2-PAM in the treatment of organophosphate toxicity in buffaloes would be 25 mg/kg followed by 22 mg/kg at 8 h intervals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11432431     DOI: 10.1023/a:1010630709407

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  16 in total

1.  Minimum concentrations of N-methylpyridinium-2-aldoxime methane sulphonate (P2S) which reverse neuromuscular block.

Authors:  A SUNDWALL
Journal:  Biochem Pharmacol       Date:  1961-12       Impact factor: 5.858

2.  The effect of an aldoxime on acute sarin poisoning.

Authors:  T A LOOMIS
Journal:  J Pharmacol Exp Ther       Date:  1956-09       Impact factor: 4.030

3.  Enzyme induction by repeated adminstration of tetrachlorvinphos in rats.

Authors:  K Moroi; S Ushiyama; T Satoh; T Kuga
Journal:  Toxicol Appl Pharmacol       Date:  1976-08       Impact factor: 4.219

4.  Disposition kinetics of 2-pyridine aldoxime methochloride in Bubalus bubalis.

Authors:  A K Srivastava; J K Malik
Journal:  J Vet Pharmacol Ther       Date:  1989-03       Impact factor: 1.786

5.  Blood concentrations of 2,3-butanedione monoxime and some blood biochemical changes in Bubalus bubalis after intramuscular administration of this cholinesterase reactivator.

Authors:  J K Malik; A K Srivastava
Journal:  Vet Res Commun       Date:  1987       Impact factor: 2.459

6.  Renal tubular secretion of pralidoxime in man.

Authors:  R D Swartz; F R Sidell
Journal:  Proc Soc Exp Biol Med       Date:  1974-06

7.  Distribution of carboxylesterase activities in different tissues of albino rats.

Authors:  C E Mendoza; J B Shields; W E Phillips
Journal:  Comp Biochem Physiol B       Date:  1971-12-15

8.  Red cell and plasma cholinesterase activities in microsamples of human and animal blood determined simultaneously by a modified acetylthiocholine-DTNB procedure.

Authors:  G Voss; K Sachsse
Journal:  Toxicol Appl Pharmacol       Date:  1970-05       Impact factor: 4.219

9.  Intramuscular and intravenous administration of small doses of 2-pyridinium aldoxime methochloride to man.

Authors:  F R Sidell; W A Groff
Journal:  J Pharm Sci       Date:  1971-08       Impact factor: 3.534

10.  Effect of thiamine hydrochloride on the blood level of 2-formyl 1-methyl pyridinium oxime chloride (2-PAM.C1) in rats.

Authors:  S D Gupta; M V Moorthy; B L Chowdhri; A K Ghosh
Journal:  Experientia       Date:  1979-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.